Fox Transactions Named Among Finalists for M&A Advisor AwardsOctober 20, 2017 – Press Releases
Fox Rothschild LLP is pleased to announce that two transactions handled by the firm’s attorneys have been named finalists for The M&A Advisor’s 16th Annual M&A Advisor Awards.
The following transactions were recognized:
- Mid-Atlantic Corporate Federal Credit Union Reverse Merger With First Carolina Corporate Credit Union, nominated for Corporate Strategic Deal of the Year ($500 million to $1 billion)
- Sale of TangenX Technology Corporation to Repligen Corporation, nominated for Cross Border Deal of the Year ($10 million to $50 million)
These annual awards recognize the leading dealmakers, firms and transactions as selected by an independent panel of judges. The winners will be announced at the 16th Annual M&A Advisor Awards Gala on November 13 at the Metropolitan Club of New York.
Mid-Atlantic Corporate Federal Credit Union Reverse Merger With First Carolina Corporate Credit Union
A Fox team comprised of Christopher J. Pippett and Bradley S. Rodos represented Mid-Atlantic Corporate Federal Credit Union, a corporate federal credit union, in its reverse merger with First Carolina Corporate Credit Union. Fox obtained a no-action determination for HSR purposes from the FTC, which is rare for a merger of this size in this industry. The combined entity, Vizo Financial, has more than $4 billion in assets. The deal allows the combined entity to take advantage of First Carolina Corporate Credit Union’s North Carolina state charter and the North Carolina regulatory scheme while maintaining operations in both Pennsylvania and North Carolina.
Sale of TangenX Technology Corporation to Repligen Corporation
A multifaceted team of Fox attorneys – including Peter J. Tucci, M. Joel Bolstein, Michael S. Bookbinder, Seth I. Corbin, Gary A. Hecht and Susan Foreman Jordan – represented Novasep, a leading supplier of manufacturing solutions for the life science industries, in the sale of its U.S. subsidiary, TangenX Technology Corporation, to Repligen Corporation (NASDAQ: RGEN). Novasep is part of Groupe Novasep, which is based in Lyon, France. The all-cash transaction was for €37 million (approximately $39 million). TangenX is located in Shrewsbury, Massachusetts. The company develops, produces and sells tangential flow filtration (TFF) technologies that enable biomanufacturers to significantly reduce industrial purification costs of biopharmaceuticals. Its innovative single-use TFF cassettes Sius™ currently commands strong sales. This was the principal reason TangenX was so attractive to Repligen.